Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by TELA Bio, Inc.

< Previous 1 2 Next >
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Reports Second Quarter 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Participate in the Jefferies Global Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Reports First Quarter 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Participate in the JMP Securities Life Sciences Conference
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Announce First Quarter 2023 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Pricing of Public Offering of Common Stock
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Proposed Public Offering of Common Stock
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Reports Third Quarter 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
TELA Bio to Announce Third Quarter 2022 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Tickers TELA
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.